Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 2 (2005), Issue 5 (May)

1. Advanced chemoresistant breast cancer responding to multidisciplinary treatment with hyperthermia, radiotherapy, and intraarterial infusion.
   Int J Clin Oncol, 10(2): 139-43. [Abstract] [Full-text]
2. Differential sensitivities of trastuzumab (Herceptin)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors.
   Breast Cancer Res Treat, 91(2): 187-201. [Abstract] [Full-text]
3. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.
   Cancer, 103(10): 2199-207. [Abstract] [Full-text]
4. Cutaneous photosensitivity induced by paclitaxel and trastuzumab therapy associated with aberrations in the biosynthesis of porphyrins.
   J Dermatolog Treat, 16(1): 19-21. [Abstract] [Full-text]
5. A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model-based cost-effectiveness analysis.
   Ann Oncol, 16(6): 909-14. [Abstract] [Full-text]
6. Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology.
   Ann Oncol, 16: iv7-iv13. [Abstract] [Full-text]
7. Therapy of breast cancer with molecular targeting agents.
   Ann Oncol, 16: iv28-iv36. [Abstract] [Full-text]
8. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.
   J Clin Oncol, 23(16): 3676-85. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.